Jody Corbelli

Faenza, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Total neoadjuvant therapy followed by total mesorectal excision for rectal cancer in older patients real world data and proof of concept.

Total neoadjuvant therapy followed by total mesorectal excision for rectal cancer in older patients real world data and proof of concept.

Journal: Frontiers in surgery

Published: June 26, 2024

Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial.

Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial.

Journal: ESMO open

Published: May 16, 2023

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer.

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer.

Journal: Frontiers in oncology

Published: September 01, 2020

Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study.

Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study.

Journal: Cancer management and research

Published: December 18, 2018

Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol.

Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol.

Journal: Tumori

Published: May 10, 2018

Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.

Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.

Journal: Journal of chemotherapy (Florence, Italy)

Published: June 24, 2017

No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC).

No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC).

Journal: Scientific reports

Published: April 16, 2016

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.

Journal: Oncotarget

Published: February 08, 2016

Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group.

Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group.

Journal: Oncotarget

Published: October 14, 2015

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.

Journal: British journal of cancer

Published: November 24, 2013

Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases.

Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases.

Journal: Langenbeck's archives of surgery

Published: January 03, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026